What is the recommended adult dosage and treatment duration for amoxicillin‑clavulanate (Augmentin)?

Recommended Augmentin Dosing for Adults

For adults with acute bacterial rhinosinusitis (ABRS), prescribe high-dose amoxicillin-clavulanate 2000 mg/125 mg (2 grams amoxicillin with 125 mg clavulanate) orally twice daily for 5-7 days. 1

Dosing Specifics

Standard Adult Dosing

The IDSA guidelines explicitly recommend "high-dose" amoxicillin-clavulanate at 2 g orally twice daily for empiric treatment of ABRS in adults 1. This high-dose formulation is preferred over standard dosing to achieve adequate coverage against resistant Streptococcus pneumoniae and beta-lactamase producing organisms.

Alternative standard-dose formulations include:

• 875 mg/125 mg twice daily - This is the most common alternative formulation 2, 3
• 500 mg/125 mg three times daily - Less commonly used due to decreased compliance

Treatment Duration

Adults: 5-7 days for uncomplicated ABRS 1

This shorter duration is supported by the IDSA guidelines (weak recommendation, low-moderate quality evidence). Research confirms that 5-day courses of high-dose formulations are as effective as 7-day courses 4.

Important caveat: If treating children, the duration extends to 10-14 days 1. This is a critical distinction that prevents treatment failure in pediatric populations.

Administration Guidelines

• Take at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 2
• Ensure adequate hydration
• Complete the full course even if symptoms improve early 2

Context-Specific Dosing

For Skin/Soft Tissue Infections

For necrotizing infections or surgical site infections, broader coverage may be needed:

• Piperacillin-tazobactam 3.375 g every 6 hours IV or 4.5 g every 8 hours IV 5
• Amoxicillin-clavulanate alone may be insufficient for polymicrobial or severe infections

For Respiratory Infections Beyond Sinusitis

Studies demonstrate that 875 mg/125 mg twice daily for 7-15 days is effective for lower respiratory tract infections and acute exacerbations of chronic bronchitis 4, 6. The twice-daily dosing shows equivalent efficacy to three-times-daily regimens with potentially better compliance.

Common Pitfalls to Avoid

1. Don't substitute formulations arbitrarily: The 200 mg/5 mL and 400 mg/5 mL suspensions contain different amounts of clavulanate and are NOT interchangeable with other formulations 2

2. Don't underdose: Standard-dose amoxicillin-clavulanate (875/125 mg) showed no benefit over high-dose (2000/125 mg) in recent trials for sinusitis, but high-dose remains guideline-recommended 7

3. Monitor for diarrhea: Approximately 40% of patients experience diarrhea, with 7% reporting severe diarrhea 7. This is dose-related but not significantly different between standard and high-dose formulations.

4. Storage matters: Improper storage in hot environments degrades the antibiotic, leading to treatment failure 8. Counsel patients to refrigerate reconstituted suspensions and avoid heat exposure.

5. Hepatic monitoring: Dose with caution in hepatically impaired patients and monitor liver function regularly 2

Drug Interactions

• Probenecid: Increases amoxicillin blood levels; concurrent use not recommended 2
• Oral anticoagulants: Monitor INR closely as amoxicillin can prolong prothrombin time 2
• Oral contraceptives: May reduce efficacy; advise backup contraception 2
• Allopurinol: Increases risk of rash when combined with ampicillin-class antibiotics 2

Special Populations

• Pregnancy: Category B - use only if clearly needed 2
• Nursing mothers: Excreted in breast milk; use with caution 2
• Phenylketonurics: Each 5 mL of ES-600 suspension contains 7 mg phenylalanine 2